XLON
HUW
Market cap231mUSD
Oct 09, Last price
255.00GBP
1D
0.00%
1Q
16.97%
Jan 2017
65.55%
IPO
157.89%
Name
Helios Underwriting PLC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Helios Underwriting plc offers its shareholders a means of limited liability investment within the distinguished Lloyd's insurance market in the United Kingdom. The company's operations are divided into three principal areas: Syndicate Participation, Investment Management, and various Other Corporate Activities. Its involvement in the Lloyd's market is primarily managed through a diverse array of Lloyd's syndicates, which focus on delivering property insurance and reinsurance solutions. Founded in 2006 and headquartered in London, UK, the firm was formerly known as Hampden Underwriting Plc before adopting its current name in January 2014.
Related entities
Subsidiaries (8)
HAMPDEN CORPORATE MEMBER LIMITED
NAMECO (NO. 518) LIMITED
NAMECO (NO.321) LIMITED
NAMECO (NO.365) LIMITED
NAMECO (NO.605) LIMITED
NAMECO (NO.804) LIMITED
NOMINA NO 380 LLP
NOMINA NO. 035 LLP
Key people
John Chambers
Interim Executive Chairman of the Board · since 2025
Nigel Hanbury
Non-Executive Deputy Chairman · since 2024
Adhiraj Maitra
Finance Director and Operations , Executive Director · since 2025
Arthur Manners
Finance Director, Executive Director · since 2021
David Shawe
Finance Controller · since 2024
Louis de Normanville Tucker
Chief Executive Officer, Executive Director · since 2025
Tan Jen
Head of Portfolio Management · since 2024
Jen Tan
Chief Underwriting Officer · since 2026
Andrew Christie
Non-Executive Independent Director · since 2018
Thomas Libassi
Non-Executive Independent Director · since 2021
Joanna Parsons
Non-Executive Independent Director · since 2025
Katharine Wade
Non-Executive Independent Director · since 2024
Headquarters & legal address
1ST FLOOR 33 CORNHILL
LONDON, LND EC3V 3ND
GB
LONDON, LND EC3V 3ND
GB
Previous name
HAMPDEN UNDERWRITING PLC
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||